Neuron-specific enolase.
The clinical value of neuron-specific enolase as a marker is small cell lung cancer, neuroblastoma, melanoma and seminoma has been reviewed. The role of serum and cerebrospinal NSE in benign and malignant disease of the central nervous system is discussed.
Cooper
E H
EH
Department of Chemical Pathology, University of Leeds, UK.
D015415:Biomarkers / Q000032:analysis*; D001930:Brain Injuries / Q000201:enzymology; D002289:Carcinoma, Non-Small-Cell Lung / Q000201:enzymology; D018288:Carcinoma, Small Cell / Q000201:enzymology; D002493:Central Nervous System Diseases / Q000201:enzymology; D006801:Humans; D008175:Lung Neoplasms / Q000201:enzymology; D008545:Melanoma / Q000201:enzymology; D009447:Neuroblastoma / Q000201:enzymology; D010751:Phosphopyruvate Hydratase / Q000032:analysis*; D016066:Pleural Effusion, Malignant / Q000201:enzymology; D018239:Seminoma / Q000201:enzymology
D015415:Biomarkers; D010751:Phosphopyruvate Hydratase